Angiotensin receptor- neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure. Drug Discov Today: Ther Strateg. 2012;9:e131 9. 62. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658 66. 63. Costanzo MR, Stevenson LW, Adamson PB, et al. Interventions linked to decreased heart failure hospi- talizations during ambulatory pulmonary artery pres- sure monitoring. J Am Coll Cardiol HF. 2016;4:333 44. 64. Fang JC, Ewald GA, Allen LA, et al. Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. J Card Fail. 2015;21:519 34. 65. Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scienti c statement from the American Heart Association. Circulation. 2012;125:1928 52. 66. Ehrmann Feldman D, Xiao Y, Bernatsky S, et al. Consultation with cardiologists for persons with new- onset chronic heart failure: a population-based study. Can J Cardiol. 2009;25:690 4. 67. Fanaroff AC, DeVore AD, Mentz RJ, et al. Patient selection for advanced heart failure therapy referral. Crit Pathw Cardiol. 2014;13:1 5. 68. Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157 87. 69. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates 2006. J Heart Lung Transplant. 2006;25:1024 42. 70. Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year up- date. J Heart Lung Transplant. 2016;35:1 23. 71. Guglin M, Zucker MJ, Borlaug BA, et al. 